BRD4 and inflammatory response: Therefore, in this study, the role of BRD4 was investigated in a model system of endothelial inflammation to better understand whether pharmacological BRD4 inhibition with apabetalone and JQ1 might be sufficient to prevent endothelial monolayer disturbance during the inflammatory response.